Management of advanced hepatocellular carcinoma in the era of targeted therapy

T Yau, P Chan, R Epstein, RTP Poon - Liver international, 2009 - Wiley Online Library
Systemic chemotherapy has had a disappointing track record in the management of
advanced hepatocellular carcinoma (HCC). Single‐agent doxorubicin produces a response …

Management of advanced hepatocellular carcinoma in the era of targeted therapy.

T Yau, P Chan, R Epstein, RTP Poon - Liver International, 2009 - search.ebscohost.com
Systemic chemotherapy has had a disappointing track record in the management of
advanced hepatocellular carcinoma (HCC). Single-agent doxorubicin produces a response …

Management of advanced hepatocellular carcinoma in the era of targeted therapy

T Yau, P Chan, R Epstein, RTP Poon - Liver International, 2009 - hub.hku.hk
Systemic chemotherapy has had a disappointing track record in the management of
advanced hepatocellular carcinoma (HCC). Single-agent doxorubicin produces a response …

Management of advanced hepatocellular carcinoma in the era of targeted therapy

T Yau, P Chan, R Epstein… - … : official journal of the …, 2009 - pubmed.ncbi.nlm.nih.gov
Systemic chemotherapy has had a disappointing track record in the management of
advanced hepatocellular carcinoma (HCC). Single-agent doxorubicin produces a response …

[引用][C] Management of advanced hepatocellular carcinoma in the era of targeted therapy

T Yau, P Chan, R Epstein, RTP Poon - Liver International, 2009 - cir.nii.ac.jp
Management of advanced hepatocellular carcinoma in the era of targeted therapy | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …

Management of advanced hepatocellular carcinoma in the era of targeted therapy.

T Yau, P Chan, R Epstein, RT Poon - … for the Study of the Liver, 2009 - europepmc.org
Systemic chemotherapy has had a disappointing track record in the management of
advanced hepatocellular carcinoma (HCC). Single-agent doxorubicin produces a response …